Global Malignant Melanoma Drugs Market Size, Status and Forecast 2025

March 2018 | 103 pages | ID: G9A96CFD33DQEN
QYResearch

Abstracts

This report studies the global Malignant Melanoma Drugs market, analyzes and researches the Malignant Melanoma Drugs development status and forecast in United States, EU, Japan, China, India and Southeast Asia.
This report focuses on the top players in global market, like

• Bristol-Myers Squibb
• Enzon Pharmaceuticals
• Exelixis
• GlaxoSmithKline
• Merck
• Pfizer
• Janssen Biotech
• Hoffmann-La Roche Ltd
• Navidea Biopharmaceuticals
• Novartis
• Ono Pharmaceutical
• Amgen

Market segment by Regions/Countries, this report covers

• United States
• EU
• Japan
• China
• India
• Southeast Asia

Market segment by Type, the product can be split into

• Immunotherapy
• Targeted Therapy
• Other

Market segment by Application, Malignant Melanoma Drugs can be split into

• Hospitals
• Clinics
• Other

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

Global Malignant Melanoma Drugs Market Size, Status and Forecast 2025

1 INDUSTRY OVERVIEW OF MALIGNANT MELANOMA DRUGS

1.1 Malignant Melanoma Drugs Market Overview
  1.1.1 Malignant Melanoma Drugs Product Scope
  1.1.2 Market Status and Outlook
1.2 Global Malignant Melanoma Drugs Market Size and Analysis by Regions (2013-2018)
  1.2.1 United States
  1.2.2 EU
  1.2.3 Japan
  1.2.4 China
  1.2.5 India
  1.2.6 Southeast Asia
1.3 Malignant Melanoma Drugs Market by Type
  1.3.1 Immunotherapy
  1.3.2 Targeted Therapy
  1.3.3 Other
1.4 Malignant Melanoma Drugs Market by End Users/Application
  1.4.1 Hospitals
  1.4.2 Clinics
  1.4.3 Other

2 GLOBAL MALIGNANT MELANOMA DRUGS COMPETITION ANALYSIS BY PLAYERS

2.1 Malignant Melanoma Drugs Market Size (Value) by Players (2013-2018)
2.2 Competitive Status and Trend
  2.2.1 Market Concentration Rate
  2.2.2 Product/Service Differences
  2.2.3 New Entrants
  2.2.4 The Technology Trends in Future

3 COMPANY (TOP PLAYERS) PROFILES

3.1 Bristol-Myers Squibb
  3.1.1 Company Profile
  3.1.2 Main Business/Business Overview
  3.1.3 Products, Services and Solutions
  3.1.4 Malignant Melanoma Drugs Revenue (Million USD) (2013-2018)
  3.1.5 Recent Developments
3.2 Enzon Pharmaceuticals
  3.2.1 Company Profile
  3.2.2 Main Business/Business Overview
  3.2.3 Products, Services and Solutions
  3.2.4 Malignant Melanoma Drugs Revenue (Million USD) (2013-2018)
  3.2.5 Recent Developments
3.3 Exelixis
  3.3.1 Company Profile
  3.3.2 Main Business/Business Overview
  3.3.3 Products, Services and Solutions
  3.3.4 Malignant Melanoma Drugs Revenue (Million USD) (2013-2018)
  3.3.5 Recent Developments
3.4 GlaxoSmithKline
  3.4.1 Company Profile
  3.4.2 Main Business/Business Overview
  3.4.3 Products, Services and Solutions
  3.4.4 Malignant Melanoma Drugs Revenue (Million USD) (2013-2018)
  3.4.5 Recent Developments
3.5 Merck
  3.5.1 Company Profile
  3.5.2 Main Business/Business Overview
  3.5.3 Products, Services and Solutions
  3.5.4 Malignant Melanoma Drugs Revenue (Million USD) (2013-2018)
  3.5.5 Recent Developments
3.6 Pfizer
  3.6.1 Company Profile
  3.6.2 Main Business/Business Overview
  3.6.3 Products, Services and Solutions
  3.6.4 Malignant Melanoma Drugs Revenue (Million USD) (2013-2018)
  3.6.5 Recent Developments
3.7 Janssen Biotech
  3.7.1 Company Profile
  3.7.2 Main Business/Business Overview
  3.7.3 Products, Services and Solutions
  3.7.4 Malignant Melanoma Drugs Revenue (Million USD) (2013-2018)
  3.7.5 Recent Developments
3.8 Hoffmann-La Roche Ltd
  3.8.1 Company Profile
  3.8.2 Main Business/Business Overview
  3.8.3 Products, Services and Solutions
  3.8.4 Malignant Melanoma Drugs Revenue (Million USD) (2013-2018)
  3.8.5 Recent Developments
3.9 Navidea Biopharmaceuticals
  3.9.1 Company Profile
  3.9.2 Main Business/Business Overview
  3.9.3 Products, Services and Solutions
  3.9.4 Malignant Melanoma Drugs Revenue (Million USD) (2013-2018)
  3.9.5 Recent Developments
3.10 Novartis
  3.10.1 Company Profile
  3.10.2 Main Business/Business Overview
  3.10.3 Products, Services and Solutions
  3.10.4 Malignant Melanoma Drugs Revenue (Million USD) (2013-2018)
  3.10.5 Recent Developments
3.11 Ono Pharmaceutical
3.12 Amgen

4 GLOBAL MALIGNANT MELANOMA DRUGS MARKET SIZE BY TYPE AND APPLICATION (2013-2018)

4.1 Global Malignant Melanoma Drugs Market Size by Type (2013-2018)
4.2 Global Malignant Melanoma Drugs Market Size by Application (2013-2018)
4.3 Potential Application of Malignant Melanoma Drugs in Future
4.4 Top Consumer/End Users of Malignant Melanoma Drugs

5 UNITED STATES MALIGNANT MELANOMA DRUGS DEVELOPMENT STATUS AND OUTLOOK

5.1 United States Malignant Melanoma Drugs Market Size (2013-2018)
5.2 United States Malignant Melanoma Drugs Market Size and Market Share by Players (2013-2018)
5.3 United States Malignant Melanoma Drugs Market Size by Application (2013-2018)

6 EU MALIGNANT MELANOMA DRUGS DEVELOPMENT STATUS AND OUTLOOK

6.1 EU Malignant Melanoma Drugs Market Size (2013-2018)
6.2 EU Malignant Melanoma Drugs Market Size and Market Share by Players (2013-2018)
6.3 EU Malignant Melanoma Drugs Market Size by Application (2013-2018)

7 JAPAN MALIGNANT MELANOMA DRUGS DEVELOPMENT STATUS AND OUTLOOK

7.1 Japan Malignant Melanoma Drugs Market Size (2013-2018)
7.2 Japan Malignant Melanoma Drugs Market Size and Market Share by Players (2013-2018)
7.3 Japan Malignant Melanoma Drugs Market Size by Application (2013-2018)

8 CHINA MALIGNANT MELANOMA DRUGS DEVELOPMENT STATUS AND OUTLOOK

8.1 China Malignant Melanoma Drugs Market Size (2013-2018)
8.2 China Malignant Melanoma Drugs Market Size and Market Share by Players (2013-2018)
8.3 China Malignant Melanoma Drugs Market Size by Application (2013-2018)

9 INDIA MALIGNANT MELANOMA DRUGS DEVELOPMENT STATUS AND OUTLOOK

9.1 India Malignant Melanoma Drugs Market Size (2013-2018)
9.2 India Malignant Melanoma Drugs Market Size and Market Share by Players (2013-2018)
9.3 India Malignant Melanoma Drugs Market Size by Application (2013-2018)

10 SOUTHEAST ASIA MALIGNANT MELANOMA DRUGS DEVELOPMENT STATUS AND OUTLOOK

10.1 Southeast Asia Malignant Melanoma Drugs Market Size (2013-2018)
10.2 Southeast Asia Malignant Melanoma Drugs Market Size and Market Share by Players (2013-2018)
10.3 Southeast Asia Malignant Melanoma Drugs Market Size by Application (2013-2018)

11 MARKET FORECAST BY REGIONS, TYPE AND APPLICATION (2018-2025)

11.1 Global Malignant Melanoma Drugs Market Size (Value) by Regions (2018-2025)
  11.1.1 United States Malignant Melanoma Drugs Revenue and Growth Rate (2018-2025)
  11.1.2 EU Malignant Melanoma Drugs Revenue and Growth Rate (2018-2025)
  11.1.3 Japan Malignant Melanoma Drugs Revenue and Growth Rate (2018-2025)
  11.1.4 China Malignant Melanoma Drugs Revenue and Growth Rate (2018-2025)
  11.1.5 India Malignant Melanoma Drugs Revenue and Growth Rate (2018-2025)
  11.1.6 Southeast Asia Malignant Melanoma Drugs Revenue and Growth Rate (2018-2025)
11.2 Global Malignant Melanoma Drugs Market Size (Value) by Type (2018-2025)
11.3 Global Malignant Melanoma Drugs Market Size by Application (2018-2025)

12 MALIGNANT MELANOMA DRUGS MARKET DYNAMICS

12.1 Malignant Melanoma Drugs Market Opportunities
12.2 Malignant Melanoma Drugs Challenge and Risk
  12.2.1 Competition from Opponents
  12.2.2 Downside Risks of Economy
12.3 Malignant Melanoma Drugs Market Constraints and Threat
  12.3.1 Threat from Substitute
  12.3.2 Government Policy
  12.3.3 Technology Risks
12.4 Malignant Melanoma Drugs Market Driving Force
  12.4.1 Growing Demand from Emerging Markets
  12.4.2 Potential Application

13 MARKET EFFECT FACTORS ANALYSIS

13.1 Technology Progress/Risk
  13.1.1 Substitutes
  13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs Trend/Customer Preference
13.3 External Environmental Change
  13.3.1 Economic Fluctuations
  13.3.2 Other Risk Factors

14 RESEARCH FINDING/CONCLUSION

15 APPENDIX

Methodology
Analyst Introduction
Data Source

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Global Malignant Melanoma Drugs Market Size (Million USD) Status and Outlook (2013-2018)
Table Global Malignant Melanoma Drugs Revenue (Million USD) Comparison by Regions (2013-2018)
Figure Global Malignant Melanoma Drugs Market Share by Regions (2013-2018)
Figure United States Malignant Melanoma Drugs Market Size (Million USD) and Growth Rate by Regions (2013-2018)
Figure EU Malignant Melanoma Drugs Market Size (Million USD) and Growth Rate by Regions (2013-2018)
Figure Japan Malignant Melanoma Drugs Market Size (Million USD) and Growth Rate by Regions (2013-2018)
Figure China Malignant Melanoma Drugs Market Size (Million USD) and Growth Rate by Regions (2013-2018)
Figure India Malignant Melanoma Drugs Market Size (Million USD) and Growth Rate by Regions (2013-2018)
Figure Southeast Asia Malignant Melanoma Drugs Market Size (Million USD) and Growth Rate by Regions (2013-2018)
Table Global Malignant Melanoma Drugs Revenue (Million USD) and Growth Rate (%) Comparison by Product (2013-2018)
Figure Global Malignant Melanoma Drugs Revenue Market Share by Type in 2017
Figure Immunotherapy Market Size (Million USD) and Growth Rate (2013-2018)
Figure Targeted Therapy Market Size (Million USD) and Growth Rate (2013-2018)
Figure Other Market Size (Million USD) and Growth Rate (2013-2018)
Figure Global Malignant Melanoma Drugs Market Share by Application in 2017
Figure Malignant Melanoma Drugs Market Size (Million USD) and Growth Rate in Hospitals (2013-2018)
Figure Malignant Melanoma Drugs Market Size (Million USD) and Growth Rate in Clinics (2013-2018)
Figure Malignant Melanoma Drugs Market Size (Million USD) and Growth Rate in Other (2013-2018)
Table Malignant Melanoma Drugs Market Size (Million USD) by Players (2013-2018)
Figure Malignant Melanoma Drugs Market Size Share by Players in 2013
Figure Malignant Melanoma Drugs Market Size Share by Players in 2017
Table Bristol-Myers Squibb Basic Information List
Table Malignant Melanoma Drugs Business Revenue (Million USD) of Bristol-Myers Squibb (2013-2018)
Figure Bristol-Myers Squibb Malignant Melanoma Drugs Business Revenue Market Share (2013-2018)
Table Enzon Pharmaceuticals Basic Information List
Table Malignant Melanoma Drugs Business Revenue (Million USD) of Enzon Pharmaceuticals (2013-2018)
Figure Enzon Pharmaceuticals Malignant Melanoma Drugs Business Revenue Market Share (2013-2018)
Table Exelixis Basic Information List
Table Malignant Melanoma Drugs Business Revenue (Million USD) of Exelixis (2013-2018)
Figure Exelixis Malignant Melanoma Drugs Business Revenue Market Share (2013-2018)
Table GlaxoSmithKline Basic Information List
Table Malignant Melanoma Drugs Business Revenue (Million USD) of GlaxoSmithKline (2013-2018)
Figure GlaxoSmithKline Malignant Melanoma Drugs Business Revenue Market Share (2013-2018)
Table Merck Basic Information List
Table Malignant Melanoma Drugs Business Revenue (Million USD) of Merck (2013-2018)
Figure Merck Malignant Melanoma Drugs Business Revenue Market Share (2013-2018)
Table Pfizer Basic Information List
Table Malignant Melanoma Drugs Business Revenue (Million USD) of Pfizer (2013-2018)
Figure Pfizer Malignant Melanoma Drugs Business Revenue Market Share (2013-2018)
Table Janssen Biotech Basic Information List
Table Malignant Melanoma Drugs Business Revenue (Million USD) of Janssen Biotech (2013-2018)
Figure Janssen Biotech Malignant Melanoma Drugs Business Revenue Market Share (2013-2018)
Table Hoffmann-La Roche Ltd Basic Information List
Table Malignant Melanoma Drugs Business Revenue (Million USD) of Hoffmann-La Roche Ltd (2013-2018)
Figure Hoffmann-La Roche Ltd Malignant Melanoma Drugs Business Revenue Market Share (2013-2018)
Table Navidea Biopharmaceuticals Basic Information List
Table Malignant Melanoma Drugs Business Revenue (Million USD) of Navidea Biopharmaceuticals (2013-2018)
Figure Navidea Biopharmaceuticals Malignant Melanoma Drugs Business Revenue Market Share (2013-2018)
Table Novartis Basic Information List
Table Malignant Melanoma Drugs Business Revenue (Million USD) of Novartis (2013-2018)
Figure Novartis Malignant Melanoma Drugs Business Revenue Market Share (2013-2018)
Table Ono Pharmaceutical Basic Information List
Table Malignant Melanoma Drugs Business Revenue (Million USD) of Ono Pharmaceutical (2013-2018)
Figure Ono Pharmaceutical Malignant Melanoma Drugs Business Revenue Market Share (2013-2018)
Table Amgen Basic Information List
Table Malignant Melanoma Drugs Business Revenue (Million USD) of Amgen (2013-2018)
Figure Amgen Malignant Melanoma Drugs Business Revenue Market Share (2013-2018)
Table Global Malignant Melanoma Drugs Market Size (Million USD) by Product (2013-2018)
Figure Global Malignant Melanoma Drugs Revenue Market Share (%) by Product (2013-2018)
Figure Global Malignant Melanoma Drugs Market Share by Product in 2017
Table Global Malignant Melanoma Drugs Market Size by Application (2013-2018)
Figure Global Malignant Melanoma Drugs Revenue Market Share (%) by Application in 2017
Table Top Consumer/End Users of Malignant Melanoma Drugs
Figure United States Malignant Melanoma Drugs Market Size (Million USD) and Growth Rate (2013-2018)
Table United States Malignant Melanoma Drugs Market Size (Million USD) by Players (2013-2018)
Figure United States Malignant Melanoma Drugs Market Size Share by Players in 2013
Figure United States Malignant Melanoma Drugs Market Size Share by Players in 2017
Table United States Malignant Melanoma Drugs Market Size by Application (2013-2018)
Figure United States Malignant Melanoma Drugs Revenue Market Share (%) by Application (2013-2018)
Figure United States Malignant Melanoma Drugs Market Size Share by Application in 2017
Figure EU Malignant Melanoma Drugs Market Size (Million USD) and Growth Rate (2013-2018)
Table EU Malignant Melanoma Drugs Market Size (Million USD) by Players (2013-2018)
Figure EU Malignant Melanoma Drugs Market Size Share by Players in 2013
Figure EU Malignant Melanoma Drugs Market Size Share by Players in 2017
Table EU Malignant Melanoma Drugs Market Size by Application (2013-2018)
Figure EU Malignant Melanoma Drugs Revenue Market Share (%) by Application (2013-2018)
Figure EU Malignant Melanoma Drugs Market Size Share by Application in 2017
Figure Japan Malignant Melanoma Drugs Market Size (Million USD) and Growth Rate (2013-2018)
Table Japan Malignant Melanoma Drugs Market Size (Million USD) by Players (2013-2018)
Figure Japan Malignant Melanoma Drugs Market Size Share by Players in 2013
Figure Japan Malignant Melanoma Drugs Market Size Share by Players in 2017
Table Japan Malignant Melanoma Drugs Market Size by Application (2013-2018)
Figure Japan Malignant Melanoma Drugs Revenue Market Share (%) by Application (2013-2018)
Figure Japan Malignant Melanoma Drugs Market Size Share by Application in 2017
Figure China Malignant Melanoma Drugs Market Size (Million USD) and Growth Rate (2013-2018)
Table China Malignant Melanoma Drugs Market Size (Million USD) by Players (2013-2018)
Figure China Malignant Melanoma Drugs Market Size Share by Players in 2013
Figure China Malignant Melanoma Drugs Market Size Share by Players in 2017
Table China Malignant Melanoma Drugs Market Size by Application (2013-2018)
Figure China Malignant Melanoma Drugs Revenue Market Share (%) by Application (2013-2018)
Figure China Malignant Melanoma Drugs Market Size Share by Application in 2017
Figure India Malignant Melanoma Drugs Market Size (Million USD) and Growth Rate (2013-2018)
Table India Malignant Melanoma Drugs Market Size (Million USD) by Players (2013-2018)
Figure India Malignant Melanoma Drugs Market Size Share by Players in 2013
Figure India Malignant Melanoma Drugs Market Size Share by Players in 2017
Table India Malignant Melanoma Drugs Market Size by Application (2013-2018)
Figure India Malignant Melanoma Drugs Revenue Market Share (%) by Application (2013-2018)
Figure India Malignant Melanoma Drugs Market Size Share by Application in 2017
Figure Southeast Asia Malignant Melanoma Drugs Market Size (Million USD) and Growth Rate (2013-2018)
Table Southeast Asia Malignant Melanoma Drugs Market Size (Million USD) by Players (2013-2018)
Figure Southeast Asia Malignant Melanoma Drugs Market Size Share by Players in 2013
Figure Southeast Asia Malignant Melanoma Drugs Market Size Share by Players in 2017
Table Southeast Asia Malignant Melanoma Drugs Market Size by Application (2013-2018)
Figure Southeast Asia Malignant Melanoma Drugs Revenue Market Share (%) by Application (2013-2018)
Figure Southeast Asia Malignant Melanoma Drugs Market Size Share by Application in 2017
Figure Global Malignant Melanoma Drugs Market Size and Growth Rate (2018-2025)
Table Global Malignant Melanoma Drugs Market Size (Million USD) by Regions (2018-2025)
Figure Global Malignant Melanoma Drugs Market Size Share (2018-2025)
Figure Global Malignant Melanoma Drugs Market Size Share by Regions in 2025
Figure United States Malignant Melanoma Drugs Revenue (Million USD) and Growth Rate (2018-2025)
Figure EU Malignant Melanoma Drugs Revenue (Million USD) and Growth Rate (2018-2025)
Figure Japan Malignant Melanoma Drugs Revenue (Million USD) and Growth Rate (2018-2025)
Figure China Malignant Melanoma Drugs Revenue (Million USD) and Growth Rate (2018-2025)
Figure India Malignant Melanoma Drugs Revenue (Million USD) and Growth Rate (2018-2025)
Figure Southeast Asia Malignant Melanoma Drugs Revenue (Million USD) and Growth Rate (2018-2025)
Table Global Malignant Melanoma Drugs Market Size (Million USD) by Type (2018-2025)
Figure Global Malignant Melanoma Drugs Market Size Share by Type in 2018
Figure Global Malignant Melanoma Drugs Market Size Share by Type in 2025
Table Global Malignant Melanoma Drugs Market Size (Million USD) by Application (2018-2025)
Figure Global Malignant Melanoma Drugs Market Size (Million USD) by Application in 2018
Figure Global Malignant Melanoma Drugs Market Size (Million USD) by Application in 2025